Archives

The fall in the share price of Galileo might be because of the overall materials index. At 4.17 PM AEDT, the ASX 200 Materials index was 1.17% down at 16,012.10 points today.

• October 07, 2022 05:28 PM AEDT
• Bhawna Gupta

Highlights,MediKane aims to become a dominant player in the safe plant-based ‘Food-as-Medicine’ health space.,The company’s products target common global chronic health conditions.,MediKane is guided by a highly skilled and experienced team.,MediKane,is a...

• October 07, 2022 04:25 PM AEDT
• Aditi Sarkar

Highlights,EarlyBirds helps businesses tap into innovations in various aspects of data management and analytics globally.,Data has been called the oil of the digital era and can be used by organisations to develop an enormous competitive advantage and dri...

• October 07, 2022 04:09 PM AEDT
• Mohammad Zaid

Another byproduct of nickel sulphide and laterite ore is nickel sulphate, which is a vital component of the batteries that powers electric vehicles.

• October 07, 2022 04:00 PM AEDT
• Bhawna Gupta

Highlights,Vertex Minerals (ASX:VTX) has discovered several unassayed pegmatite intersections via a review of drill logs at the Taylors Rock Project.,The Taylors Rock Nickel Gold Project has not been subjected to any previous exploration for lithium.,VTX ...

• October 07, 2022 03:51 PM AEDT
• Mohammad Zaid

Shares of GQG are trading in red today. According to GQG's media release, FUM of the company dropped in September.

• October 07, 2022 03:07 PM AEDT
• Sonal Goyal

Highlights,The prominent scientific journal ‘Nature’ has published an authoritative analysis of the role of LRRC15 in cancer growth.,The article highlights that LRRC15 proteins on cancer-associated fibroblasts (CAFs) protect tumour cells from the immune s...

• October 07, 2022 02:55 PM AEDT
• Aditi Sarkar

Highlights,Imugene Limited will be giving an oral presentation of an abstract about the overall survival results from its HER-Vaxx HERIZON study at the ESMO Asia Congress 2022,The event will be held from 2-4 December in Singapore,Principal investigator Ma...

• October 07, 2022 02:37 PM AEDT
• Manisha

Highlights,Chimeric substantially bolstered its portfolio and advanced clinical development during FY22.,The period saw the licensing of a novel CAR T cell therapy from the University of Pennsylvania.,The company continued to advance its first asset in a ...

• October 07, 2022 02:30 PM AEDT
• Aditi Sarkar

The first sale of a spodumene DSO product (1.4% Li2O) from Core Lithium's Finniss Project was completed on 3 October 2022, according to an ASX filing.

• October 07, 2022 01:46 PM AEDT
• Bhawna Gupta